Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.
Identifieur interne : 000123 ( PubMed/Checkpoint ); précédent : 000122; suivant : 000124Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.
Auteurs : Mark R. Brincat [Malte] ; Yves Muscat BaronSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2017.
Abstract
Lymph node metastasis has been shown to represent the most significant prognostic factor in vulvar carcinoma. Because only 25% to 35% of patients with early stage disease have lymph node metastases, a significant 65% to 75% possibly do not benefit from elective inguinofemoral lymphadenectomy considering the related morbidities of wound infection, breakdown, and lower limb lymphedema. This review article aims to present and summarize the evidence available with regard to sentinel lymph node (SLN)-guided management of vulvar carcinoma.
DOI: 10.1097/IGC.0000000000001075
PubMed: 28763369
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:28763369Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.</title><author><name sortKey="Brincat, Mark R" sort="Brincat, Mark R" uniqKey="Brincat M" first="Mark R" last="Brincat">Mark R. Brincat</name><affiliation wicri:level="1"><nlm:affiliation>Mater Dei Hospital, Msida, Malta.</nlm:affiliation><country xml:lang="fr">Malte</country><wicri:regionArea>Mater Dei Hospital, Msida</wicri:regionArea><wicri:noRegion>Msida</wicri:noRegion></affiliation></author><author><name sortKey="Muscat Baron, Yves" sort="Muscat Baron, Yves" uniqKey="Muscat Baron Y" first="Yves" last="Muscat Baron">Yves Muscat Baron</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28763369</idno><idno type="pmid">28763369</idno><idno type="doi">10.1097/IGC.0000000000001075</idno><idno type="wicri:Area/PubMed/Corpus">000067</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000067</idno><idno type="wicri:Area/PubMed/Curation">000067</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000067</idno><idno type="wicri:Area/PubMed/Checkpoint">000067</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000067</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.</title><author><name sortKey="Brincat, Mark R" sort="Brincat, Mark R" uniqKey="Brincat M" first="Mark R" last="Brincat">Mark R. Brincat</name><affiliation wicri:level="1"><nlm:affiliation>Mater Dei Hospital, Msida, Malta.</nlm:affiliation><country xml:lang="fr">Malte</country><wicri:regionArea>Mater Dei Hospital, Msida</wicri:regionArea><wicri:noRegion>Msida</wicri:noRegion></affiliation></author><author><name sortKey="Muscat Baron, Yves" sort="Muscat Baron, Yves" uniqKey="Muscat Baron Y" first="Yves" last="Muscat Baron">Yves Muscat Baron</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymph node metastasis has been shown to represent the most significant prognostic factor in vulvar carcinoma. Because only 25% to 35% of patients with early stage disease have lymph node metastases, a significant 65% to 75% possibly do not benefit from elective inguinofemoral lymphadenectomy considering the related morbidities of wound infection, breakdown, and lower limb lymphedema. This review article aims to present and summarize the evidence available with regard to sentinel lymph node (SLN)-guided management of vulvar carcinoma.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28763369</PMID><DateCreated><Year>2017</Year><Month>08</Month><Day>01</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title><ISOAbbreviation>Int. J. Gynecol. Cancer</ISOAbbreviation></Journal><ArticleTitle>Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/IGC.0000000000001075</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Lymph node metastasis has been shown to represent the most significant prognostic factor in vulvar carcinoma. Because only 25% to 35% of patients with early stage disease have lymph node metastases, a significant 65% to 75% possibly do not benefit from elective inguinofemoral lymphadenectomy considering the related morbidities of wound infection, breakdown, and lower limb lymphedema. This review article aims to present and summarize the evidence available with regard to sentinel lymph node (SLN)-guided management of vulvar carcinoma.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A literature search was performed in MEDLINE resources using the subject headings "vulvar neoplasms," "sentinel lymph node," "sentinel lymph node biopsy," and "lymphatic metastasis." This search returned 886 articles that were published through January 2017. Prospective studies investigating sentinel node identification techniques and their impact on vulvar cancer management and prognosis were considered. Case reports were excluded from the review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Technetium-99-m-labeled nanocolloid with or without blue dye and more recently indocyanine green fluorescence have been the main techniques used for SLN identification in vulvar carcinoma. Radioisotope and near-infrared techniques have been shown to be superior to blue dye particularly with midline lesions that drain bilaterally or that drain directly to a deep pelvic node. Patients with a small unifocal primary tumor (<4 cm) and no obvious preoperative metastasis have been shown to have low groin recurrence rates and excellent disease-specific survival rates with minimal treatment-related morbidity when undergoing SLN biopsy-guided management.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sentinel lymph node biopsy-guided management seems to be safe when restricted to International Federation of Gynecology and Obstetrics IB to II cases where tumors are unifocal, less than 4 cm in size, and when there is no evidence of lymph node metastasis on clinical/radiological assessment. This reduces operative morbidity in this cohort of patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brincat</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscat Baron</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynecol Cancer</MedlineTA><NlmUniqueID>9111626</NlmUniqueID><ISSNLinking>1048-891X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28763369</ArticleId><ArticleId IdType="doi">10.1097/IGC.0000000000001075</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Malte</li></country></list><tree><noCountry><name sortKey="Muscat Baron, Yves" sort="Muscat Baron, Yves" uniqKey="Muscat Baron Y" first="Yves" last="Muscat Baron">Yves Muscat Baron</name></noCountry><country name="Malte"><noRegion><name sortKey="Brincat, Mark R" sort="Brincat, Mark R" uniqKey="Brincat M" first="Mark R" last="Brincat">Mark R. Brincat</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000123 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000123 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:28763369
|texte= Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma: An Evidence-Based Insight.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:28763369" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |